Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder.

Einat H, Yuan P, Szabo ST, Dogra S, Manji HK.

Neuropsychobiology. 2007;55(3-4):123-31. Epub 2007 Jul 18.

PMID:
17641532
2.

Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?

Pereira M, Andreatini R, Schwarting RK, Brenes JC.

Psychopharmacology (Berl). 2014 Jul;231(13):2567-77. doi: 10.1007/s00213-013-3413-1. Epub 2014 Jan 11.

PMID:
24414610
3.

The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs.

Sabioni P, Baretta IP, Ninomiya EM, Gustafson L, Rodrigues AL, Andreatini R.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1927-31. doi: 10.1016/j.pnpbp.2008.09.023. Epub 2008 Oct 7.

PMID:
18930105
4.

Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania.

Cechinel-Recco K, Valvassori SS, Varela RB, Resende WR, Arent CO, Vitto MF, Luz G, de Souza CT, Quevedo J.

J Psychopharmacol. 2012 Dec;26(12):1594-604. doi: 10.1177/0269881112463124. Epub 2012 Oct 17.

PMID:
23076832
5.

Effects of tamoxifen on tricarboxylic acid cycle enzymes in the brain of rats submitted to an animal model of mania induced by amphetamine.

Valvassori SS, Bavaresco DV, Budni J, Bobsin TS, Gonçalves CL, de Freitas KV, Streck EL, Quevedo J.

Psychiatry Res. 2014 Feb 28;215(2):483-7. doi: 10.1016/j.psychres.2013.11.016. Epub 2013 Nov 21.

PMID:
24359811
6.

Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.

Dencker D, Husum H.

Behav Brain Res. 2010 Feb 11;207(1):78-83. doi: 10.1016/j.bbr.2009.09.040. Epub 2009 Oct 6.

PMID:
19815032
7.

Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice.

Einat H.

Pharmacol Rep. 2014 Aug;66(4):722-5. doi: 10.1016/j.pharep.2014.03.013. Epub 2014 Apr 16.

PMID:
24948079
8.

Effect of the new antiepileptic drug retigabine in a rodent model of mania.

Dencker D, Dias R, Pedersen ML, Husum H.

Epilepsy Behav. 2008 Jan;12(1):49-53.

PMID:
18086455
9.

Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania.

Szabo ST, Machado-Vieira R, Yuan P, Wang Y, Wei Y, Falke C, Cirelli C, Tononi G, Manji HK, Du J.

Neuropharmacology. 2009 Jan;56(1):47-55. doi: 10.1016/j.neuropharm.2008.08.015. Epub 2008 Aug 22.

10.

Evaluation of behavioral and neurochemical changes induced by ketamine in rats: implications as an animal model of mania.

Ghedim FV, Fraga Dde B, Deroza PF, Oliveira MB, Valvassori SS, Steckert AV, Budni J, Dal-Pizzol F, Quevedo J, Zugno AI.

J Psychiatr Res. 2012 Dec;46(12):1569-75. doi: 10.1016/j.jpsychires.2012.08.010. Epub 2012 Sep 19.

PMID:
22998743
11.

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.

Yildiz A, Guleryuz S, Ankerst DP, Ongür D, Renshaw PF.

Arch Gen Psychiatry. 2008 Mar;65(3):255-63. doi: 10.1001/archgenpsychiatry.2007.43.

PMID:
18316672
12.

Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.

Abrial E, Bétourné A, Etiévant A, Lucas G, Scarna H, Lambás-Señas L, Haddjeri N.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu031. doi: 10.1093/ijnp/pyu031.

13.

Chronic treatment with mood stabilizer lithium inhibits amphetamine-induced risk-taking manic-like behaviors.

Zhou Z, Wang Y, Tan H, Bharti V, Che Y, Wang JF.

Neurosci Lett. 2015 Aug 31;603:84-8. doi: 10.1016/j.neulet.2015.07.027. Epub 2015 Jul 26.

PMID:
26219985
14.

Protein kinase C and oxidative stress in an animal model of mania.

Steckert AV, Valvassori SS, Mina F, Lopes-Borges J, Varela RB, Kapczinski F, Dal-Pizzol F, Quevedo J.

Curr Neurovasc Res. 2012 Feb;9(1):47-57.

PMID:
22272765
15.

[Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].

Einat H, Chen G, Manji H.

Harefuah. 2004 Jun;143(6):420-5, 462. Review. Hebrew.

PMID:
15524099
16.

Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats.

Abrial E, Etievant A, Bétry C, Scarna H, Lucas G, Haddjeri N, Lambás-Señas L.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:40-8. doi: 10.1016/j.pnpbp.2012.11.015. Epub 2012 Dec 8.

PMID:
23228462
17.

Na+,K+-ATPase activity in an animal model of mania.

Zugno AI, Valvassori SS, Scherer EB, Mattos C, Matté C, Ferreira CL, Rezin GT, Wyse AT, Quevedo J, Streck EL.

J Neural Transm (Vienna). 2009 Apr;116(4):431-6. doi: 10.1007/s00702-009-0198-9. Epub 2009 Mar 3.

PMID:
19255820
18.

Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania.

Frey BN, Andreazza AC, Rosa AR, Martins MR, Valvassori SS, Réus GZ, Hatch JP, Quevedo J, Kapczinski F.

Behav Pharmacol. 2006 Jun;17(4):311-8.

PMID:
16914949
19.

Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain.

Lopes-Borges J, Valvassori SS, Varela RB, Tonin PT, Vieira JS, Gonçalves CL, Streck EL, Quevedo J.

Pharmacol Biochem Behav. 2015 Jan;128:89-95. doi: 10.1016/j.pbb.2014.11.014. Epub 2014 Nov 27.

PMID:
25433326
20.

Brain creatine kinase activity in an animal model of mania.

Streck EL, Amboni G, Scaini G, Di-Pietro PB, Rezin GT, Valvassori SS, Luz G, Kapczinski F, Quevedo J.

Life Sci. 2008 Feb 13;82(7-8):424-9. doi: 10.1016/j.lfs.2007.11.026. Epub 2007 Dec 14.

PMID:
18191157

Supplemental Content

Support Center